220 related articles for article (PubMed ID: 15113713)
1. Differential eicosapentaenoic acid elevations and altered cardiovascular disease risk factor responses after supplementation with docosahexaenoic acid in postmenopausal women receiving and not receiving hormone replacement therapy.
Stark KD; Holub BJ
Am J Clin Nutr; 2004 May; 79(5):765-73. PubMed ID: 15113713
[TBL] [Abstract][Full Text] [Related]
2. Effect of a fish-oil concentrate on serum lipids in postmenopausal women receiving and not receiving hormone replacement therapy in a placebo-controlled, double-blind trial.
Stark KD; Park EJ; Maines VA; Holub BJ
Am J Clin Nutr; 2000 Aug; 72(2):389-94. PubMed ID: 10919932
[TBL] [Abstract][Full Text] [Related]
3. A randomized, crossover, head-to-head comparison of eicosapentaenoic acid and docosahexaenoic acid supplementation to reduce inflammation markers in men and women: the Comparing EPA to DHA (ComparED) Study.
Allaire J; Couture P; Leclerc M; Charest A; Marin J; Lépine MC; Talbot D; Tchernof A; Lamarche B
Am J Clin Nutr; 2016 Aug; 104(2):280-7. PubMed ID: 27281302
[TBL] [Abstract][Full Text] [Related]
4. Circulating triacylglycerol and apoE levels in response to EPA and docosahexaenoic acid supplementation in adult human subjects.
Buckley R; Shewring B; Turner R; Yaqoob P; Minihane AM
Br J Nutr; 2004 Sep; 92(3):477-83. PubMed ID: 15469651
[TBL] [Abstract][Full Text] [Related]
5. Purified eicosapentaenoic and docosahexaenoic acids have differential effects on serum lipids and lipoproteins, LDL particle size, glucose, and insulin in mildly hyperlipidemic men.
Mori TA; Burke V; Puddey IB; Watts GF; O'Neal DN; Best JD; Beilin LJ
Am J Clin Nutr; 2000 May; 71(5):1085-94. PubMed ID: 10799369
[TBL] [Abstract][Full Text] [Related]
6. Highly purified eicosapentaenoic acid and docosahexaenoic acid in humans have similar triacylglycerol-lowering effects but divergent effects on serum fatty acids.
Grimsgaard S; Bonaa KH; Hansen JB; Nordøy A
Am J Clin Nutr; 1997 Sep; 66(3):649-59. PubMed ID: 9280188
[TBL] [Abstract][Full Text] [Related]
7. Supplementation with an algae source of docosahexaenoic acid increases (n-3) fatty acid status and alters selected risk factors for heart disease in vegetarian subjects.
Conquer JA; Holub BJ
J Nutr; 1996 Dec; 126(12):3032-9. PubMed ID: 9001371
[TBL] [Abstract][Full Text] [Related]
8. Compound-specific isotope analysis reveals no retroconversion of DHA to EPA but substantial conversion of EPA to DHA following supplementation: a randomized control trial.
Metherel AH; Irfan M; Klingel SL; Mutch DM; Bazinet RP
Am J Clin Nutr; 2019 Oct; 110(4):823-831. PubMed ID: 31204771
[TBL] [Abstract][Full Text] [Related]
9. Comparing the serum TAG response to high-dose supplementation of either DHA or EPA among individuals with increased cardiovascular risk: the ComparED study.
Allaire J; Vors C; Harris WS; Jackson KH; Tchernof A; Couture P; Lamarche B
Br J Nutr; 2019 Jun; 121(11):1223-1234. PubMed ID: 30854986
[TBL] [Abstract][Full Text] [Related]
10. Effects of purified eicosapentaenoic and docosahexaenoic acids on glycemic control, blood pressure, and serum lipids in type 2 diabetic patients with treated hypertension.
Woodman RJ; Mori TA; Burke V; Puddey IB; Watts GF; Beilin LJ
Am J Clin Nutr; 2002 Nov; 76(5):1007-15. PubMed ID: 12399272
[TBL] [Abstract][Full Text] [Related]
11. Low doses of eicosapentaenoic acid and docosahexaenoic acid from fish oil dose-dependently decrease serum triglyceride concentrations in the presence of plant sterols in hypercholesterolemic men and women.
Ras RT; Demonty I; Zebregs YE; Quadt JF; Olsson J; Trautwein EA
J Nutr; 2014 Oct; 144(10):1564-70. PubMed ID: 25122648
[TBL] [Abstract][Full Text] [Related]
12. Circulating CD36+ microparticles are not altered by docosahexaenoic or eicosapentaenoic acid supplementation.
Phang M; Thorne RF; Alkhatatbeh MJ; Garg ML; Lincz LF
Nutr Metab Cardiovasc Dis; 2016 Mar; 26(3):254-60. PubMed ID: 26803595
[TBL] [Abstract][Full Text] [Related]
13. Use of manufactured foods enriched with fish oils as a means of increasing long-chain n-3 polyunsaturated fatty acid intake.
Lovegrove JA; Brooks CN; Murphy MC; Gould BJ; Williams CM
Br J Nutr; 1997 Aug; 78(2):223-36. PubMed ID: 9301413
[TBL] [Abstract][Full Text] [Related]
14. Docosahexaenoic and eicosapentaenoic acids in plasma phospholipids are divergently associated with high density lipoprotein in humans.
Bønaa KH; Bjerve KS; Nordøy A
Arterioscler Thromb; 1992 Jun; 12(6):675-81. PubMed ID: 1534256
[TBL] [Abstract][Full Text] [Related]
15. Effect of n-3 long-chain polyunsaturated fatty acids supplementation in healthy mothers on DHA and EPA profiles in maternal and umbilical blood: a randomized controlled trial.
Soldo D; Mikulić-Kajić M; Spalldi Barišić L; Penava N; Orlović M; Soldo N; Kajić M
J Perinat Med; 2019 Feb; 47(2):200-206. PubMed ID: 30315737
[TBL] [Abstract][Full Text] [Related]
16. Omega-3 fatty acids eicosapentaenoic acid and docosahexaenoic acid and their mechanisms of action on apolipoprotein B-containing lipoproteins in humans: a review.
Oscarsson J; Hurt-Camejo E
Lipids Health Dis; 2017 Aug; 16(1):149. PubMed ID: 28797250
[TBL] [Abstract][Full Text] [Related]
17. Relations between n-3 fatty acid status and cardiovascular disease risk factors among Quebecers.
Dewailly E E; Blanchet C; Gingras S; Lemieux S; Sauvé L; Bergeron J; Holub BJ
Am J Clin Nutr; 2001 Nov; 74(5):603-11. PubMed ID: 11684528
[TBL] [Abstract][Full Text] [Related]
18. Different metabolism of EPA, DPA and DHA in humans: A double-blind cross-over study.
Guo XF; Tong WF; Ruan Y; Sinclair AJ; Li D
Prostaglandins Leukot Essent Fatty Acids; 2020 Jul; 158():102033. PubMed ID: 31740197
[TBL] [Abstract][Full Text] [Related]
19. Effects of alpha-linolenic acid versus those of EPA/DHA on cardiovascular risk markers in healthy elderly subjects.
Goyens PL; Mensink RP
Eur J Clin Nutr; 2006 Aug; 60(8):978-84. PubMed ID: 16482073
[TBL] [Abstract][Full Text] [Related]
20. A short-term n-3 DPA supplementation study in humans.
Miller E; Kaur G; Larsen A; Loh SP; Linderborg K; Weisinger HS; Turchini GM; Cameron-Smith D; Sinclair AJ
Eur J Nutr; 2013 Apr; 52(3):895-904. PubMed ID: 22729967
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
